Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

About this update from Organogenesis Holdings Inc.

CANTON, Mass. , Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the following upcoming investor conferences: The Cantor Fitzgerald Global Healthcare Conference at the New York Marriott Marquis in New York, NY Management will participate in a fireside chat on Wednesday, September 3 at 2:10 p.m. Eastern Time . The Morgan Stanley Global Healthcare Conference at the Sheraton Times Square in New York, NY Management will participate in a fireside chat on Wednesday, September 10 at 2:35 p.m. Eastern Time Webcasts of the fireside chat sessions will be accessible by visiting the “News & Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com . Archives of the webcasts will be available for replay following the conference for approximately 30 days. About Organogenesis Holdings Inc. Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com Investor Inquiries: ICR Healthcare Mike Piccinino , CFA [email protected] Press and Media Inquiries: Organogenesis [email protected] Source: Organogenesis Holdings Inc.

View stock analysis, news, and events for Organogenesis Holdings Inc.